Chalk up another exit for Ralph Kauten.
Kauten, one of Wisconsin’s more successful biotech entrepreneurs, is chairman and CEO of Lucigen, a Middleton, WI-based vendor of life sciences research tools that on Friday said it has been acquired by LGC.
Arrowhead Pharmaceuticals is back in the clinic.
On Thursday, Pasadena, CA-based Arrowhead—which houses its research and development operations in Madison, WI—said regulators cleared the company to initiate a clinical study of a drug it’s developing to treat chronic hepatitis B virus.... Read more »
Silvio Micali says he mistimed his first two technology startups. But the renowned MIT professor thinks he’s hitting the market at the right moment with his latest company, Algorand, which plans to launch a blockchain-based virtual currency and transactions system this... Read more »
This week, the Ypsilanti Township, MI-based American Center for Mobility, in collaboration with AARP and Waymo, announced that it has commissioned a study on how autonomous vehicles will impact transportation jobs in the future. The study is being conducted... Read more »
Critical communications software company Everbridge has made a $33.6 million cash bid to acquire Norwegian competitor Unified Messaging Systems (UMS) in a deal that would grow its overseas presence.
Tetraphase Pharmaceuticals’ ups and downs have continued, as new data have clouded the future of the Watertown, MA, company’s experimental antibiotic, eravacycline, once again.
Tetraphase (NASDAQ: TTPH) reported that eravacycline failed a 1,200-patient Phase 3 study called Ignite3, one... Read more »
Carbonite has agreed to buy competing online data backup service Mozy from Dell Technologies for $145.8 million, according to an announcement about the company’s 2017 financial results. Carbonite said the deal expands its customer base and the number of market segments... Read more »
Director, Silicon Flatirons Centers' Entrepreneurship Initiative
Vice President for Research at UT Health Science Center at San Antonio
Chairman, CEO, & Founder, Alexandria Real Estate Equities
Professor of Systems Biology, Columbia University